Publication
The influence of metabolic syndrome in the outcomes of colorectal cancer patients
| dc.contributor.author | Goulart, A | |
| dc.contributor.author | Varejão, A | |
| dc.contributor.author | Nogueira, F | |
| dc.contributor.author | Martins, S | |
| dc.contributor.author | Mesquita-Rodrigues, A | |
| dc.contributor.author | Sousa, N | |
| dc.contributor.author | Leão, P | |
| dc.date.accessioned | 2017-09-08T10:05:45Z | |
| dc.date.available | 2017-09-08T10:05:45Z | |
| dc.date.issued | 2017-07-08 | |
| dc.description.abstract | AIMS: Determine the influence of metabolic syndrome and its different components in the outcomes of colorectal cancer surgery at 30days. MATERIALS AND METHODS: Prospective study that included all patients submitted to elective colorectal cancer surgery between August 2015 and August 2016 at Hospital de Braga. Clinical and laboratory parameters evaluated pre-operatively were: central obesity, blood pressure, fasting glucose, triglycerides levels and HDL cholesterol levels. Any complications during the first 30-days after surgery were recorded (readmission, reintervention, anastomotic dehiscence, morbimortality). RESULTS: One hundred and thirty-four patients were included. Metabolic syndrome was diagnostic in 40.7% of patients with the ATPIII definition, 67.5% with the AHA definition and 67.0% with the IDF definition. At 30days after colorectal cancer surgery, 73.1% patients don't have any complication, 15.7% have minor complications (grade I/II of Clavien-Dindo classification), 11.1% have major complications (grade III/IV/V of Clavien-Dindo classification) and 1.5% have died from surgical complications (grade V of Clavien-Dindo classification). The statistic analysis didn't reveal any association between MS, or it's different components, and surgical outcomes. CONCLUSION: This study seems to indicate that metabolic syndrome don't have any influence in surgical outcomes of colorectal cancer surgery. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Diabetes Metab Syndr. 2017 Jul 8. pii: S1871-4021(17)30176-5. | pt_PT |
| dc.identifier.doi | 10.1016/j.dsx.2017.07.007 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.23/1196 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.subject | Síndrome X Metabólica | pt_PT |
| dc.subject | Neoplasias Colorrectais | pt_PT |
| dc.title | The influence of metabolic syndrome in the outcomes of colorectal cancer patients | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |